Cite
HARVARD Citation
Wang, J. et al. (2020). Detection of measurable residual disease may better predict outcomes than mutations based on next‐generation sequencing in acute myeloid leukaemia with biallelic mutations of CEBPA. British journal of haematology. pp. 533-544. [Online].